Phase III Clinical Study Evaluating the Efficacy and Safety of WPV01 in Patients With Mild/Moderate COVID-19
Status:
Completed
Trial end date:
2023-09-20
Target enrollment:
Participant gender:
Summary
The study is a multicenter, randomized, double-blind, placebo-controlled efficacy, safety
Phase III clinical trial designed to evaluate the efficacy and safety of WPV01 in patients
with mild/moderate COVID-19.